The PMC Clinical Science Committee
The Clinical Science Committee evaluates the emerging applications of science and technology in personalized medicine, and serves as an advisory resource for other committees and for the PMC. It helps guide policies that govern communications and programs related to personalized medicine in an effort to advance it in the public sphere. The committee oversees material published on PersonalizedMedicineCoalition.org and in the PMC's other publications. It also reviews PMC communications and programs for scientific and technical accuracy. The Clinical Science Committee Chair is Jeffrey Cossman, USDS.
Correspondence From the Clinical Science Committee
Letter to the Annals of Internal Medicine from the Clinical Science Committee Re: Genetic Testing for Warfarin Sensitivity
(June 4, 2009 - PDF)
Comments to CMS on National Coverage Determinations Re: Potential National Coverage Determinations
(September 26, 2008 - PDF)
Science
- The PMC Clinical Science Committee
- General Personalized Medicine
- Drug Interactions (Toxicology)
- General Genomics
- Personal Genomics
- Personalized Disease Management
- Pharmacogenomics/ Pharmacogenetics
- PGx and Cancer
- PGx in Pain Management
- Pharmacogenomics and Cardiovascular Disease, Pharmacogenomics of Warfarin
- Pharmacogenomics and Diabetes




ShareThis